Sharon Gray
Impact in
- Modeling and Simulation top 1%
- COVID-19 epidemiological studies
- Health top 2%
- Vaccine Coverage and Hesitancy
Papers in ⓘ
- Microbiology 13
- Bacterial Infections and Vaccines 13
- Epidemiology 24
- Pneumonia and Respiratory Infections 21
- Respiratory viral infections research 18
- Co-authors
- Luis Jódar (8 shared papers)Bradley K. Ackerson (4 shared papers)John M. McLaughlin (4 shared papers)Joann M. Zamparo (6 shared papers)Jeff Slezak (4 shared papers)Sara Y. Tartof (4 shared papers)Oluwaseye Ayoola Ogun (4 shared papers)Timothy B. Frankland (4 shared papers)
- Journals
- Vaccine (3 papers)The Pediatric Infectious Disease Journal (2 papers)Clinical Infectious Diseases (1 paper)BMJ Open (1 paper)Human Vaccines & Immunotherapeutics (1 paper)
- Partner nations
- United StatesUnited KingdomCosta Rica
In The Last Decade
Sharon Gray
29 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Modeling and Simulation 223
- Health 393
- Infectious Diseases 775
- Microbiology 119
- Epidemiology 422
Countries citing papers authored by Sharon Gray
This map shows the geographic impact of Sharon Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Gray more than expected).
Fields of papers citing papers by Sharon Gray
This network shows the impact of papers produced by Sharon Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Gray. The network helps show where Sharon Gray may publish in the future.
Co-authors
The 25 scholars most cited alongside Sharon Gray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study Hit paper breakdown → | 2021 | 727 |
| 2 | 2022 | 80 | |
| 3 | 2007 | 75 | |
| 4 | 2013 | 72 | |
| 5 | 2012 | 45 | |
| 6 | 2021 | 41 | |
| 7 | 2011 | 31 | |
| 8 | 2021 | 29 | |
| 9 | 2016 | 28 | |
| 10 | 2021 | 16 | |
| 11 | 2012 | 15 | |
| 12 | 2015 | 11 | |
| 13 | 2015 | 9 | |
| 14 | 2022 | 8 | |
| 15 | 2018 | 8 | |
| 16 | 2022 | 5 | |
| 17 | 2014 | 5 | |
| 18 | 2023 | 5 | |
| 19 | 2012 | 4 | |
| 20 | 2016 | 4 |
About Sharon Gray
Sharon Gray is a scholar working on Microbiology, Epidemiology, Health, Critical Care and Intensive Care Medicine and Infectious Diseases, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (21 papers), Respiratory viral infections research (18 papers), Bacterial Infections and Vaccines (13 papers), Vaccine Coverage and Hesitancy (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Nosocomial Infections in ICU (3 papers) and Emergency and Acute Care Studies (3 papers). The work is most often cited by research in Modeling and Simulation (223 citations), Health (393 citations), Infectious Diseases (775 citations), Microbiology (119 citations) and Epidemiology (422 citations). Sharon Gray has collaborated with scholars based in United States, United Kingdom and Costa Rica. Frequent co-authors include Luis Jódar, Bradley K. Ackerson, John M. McLaughlin, Joann M. Zamparo, Jeff Slezak, Sara Y. Tartof, Oluwaseye Ayoola Ogun, Timothy B. Frankland, Vennis Hong and Srinivas Rao Valluri. Their work appears in journals such as Vaccine, The Pediatric Infectious Disease Journal, Clinical Infectious Diseases, BMJ Open and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.